| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 6 | 2016 | 440 | 1.450 |
Why?
|
| Echocardiography, Doppler | 3 | 2020 | 171 | 0.820 |
Why?
|
| Aorta | 2 | 2016 | 550 | 0.770 |
Why?
|
| Heart Atria | 3 | 2020 | 318 | 0.670 |
Why?
|
| Echocardiography | 12 | 2022 | 1055 | 0.640 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2017 | 152 | 0.620 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2017 | 10 | 0.560 |
Why?
|
| Heart Ventricles | 6 | 2022 | 770 | 0.560 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2017 | 17 | 0.560 |
Why?
|
| Heart Septal Defects, Ventricular | 5 | 2018 | 134 | 0.550 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 78 | 0.540 |
Why?
|
| Heart Aneurysm | 1 | 2016 | 40 | 0.530 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2016 | 104 | 0.510 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 163 | 0.500 |
Why?
|
| Heart Diseases | 2 | 2020 | 484 | 0.500 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 68 | 0.470 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 335 | 0.420 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2022 | 361 | 0.410 |
Why?
|
| Cyanosis | 2 | 2015 | 42 | 0.400 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 434 | 0.400 |
Why?
|
| Heart Defects, Congenital | 7 | 2015 | 1813 | 0.370 |
Why?
|
| Mass Screening | 1 | 2017 | 786 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2008 | 3573 | 0.350 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2005 | 169 | 0.290 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 53 | 0.280 |
Why?
|
| Pulmonary Atresia | 1 | 2007 | 48 | 0.280 |
Why?
|
| Heart Neoplasms | 1 | 2008 | 101 | 0.280 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2008 | 162 | 0.260 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2007 | 96 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 606 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2008 | 1237 | 0.260 |
Why?
|
| Leg | 1 | 2007 | 156 | 0.260 |
Why?
|
| Mitral Valve | 1 | 2007 | 247 | 0.250 |
Why?
|
| Venae Cavae | 1 | 2005 | 11 | 0.240 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 28 | 0.240 |
Why?
|
| Coronary Aneurysm | 1 | 2005 | 34 | 0.240 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 121 | 0.230 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2007 | 252 | 0.230 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 73 | 0.230 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 5096 | 0.230 |
Why?
|
| Humans | 38 | 2022 | 124311 | 0.220 |
Why?
|
| Esophagogastric Junction | 1 | 2004 | 28 | 0.220 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 150 | 0.220 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2018 | 962 | 0.220 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 162 | 0.210 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 275 | 0.210 |
Why?
|
| Coronary Vessels | 1 | 2007 | 539 | 0.210 |
Why?
|
| Infant | 14 | 2021 | 12463 | 0.210 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2002 | 4 | 0.200 |
Why?
|
| Anorexia Nervosa | 1 | 2002 | 24 | 0.200 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2004 | 223 | 0.190 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 480 | 0.190 |
Why?
|
| Ventricular Function, Right | 1 | 2022 | 113 | 0.180 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 964 | 0.180 |
Why?
|
| Male | 23 | 2021 | 60910 | 0.180 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 27 | 0.170 |
Why?
|
| Anthracyclines | 1 | 2020 | 36 | 0.170 |
Why?
|
| Kidney | 1 | 2007 | 1346 | 0.170 |
Why?
|
| Myocarditis | 1 | 2021 | 121 | 0.170 |
Why?
|
| Heart Failure | 3 | 2007 | 2157 | 0.170 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 127 | 0.170 |
Why?
|
| Ultrasonography | 4 | 2007 | 950 | 0.150 |
Why?
|
| Adolescent | 13 | 2021 | 19310 | 0.150 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 68 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2017 | 16 | 0.150 |
Why?
|
| Female | 17 | 2021 | 66312 | 0.140 |
Why?
|
| Glucosidases | 1 | 2017 | 2 | 0.140 |
Why?
|
| Acarbose | 1 | 2017 | 4 | 0.140 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cancer Survivors | 1 | 2020 | 206 | 0.140 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2016 | 1 | 0.140 |
Why?
|
| Neoplasms | 2 | 2022 | 2789 | 0.140 |
Why?
|
| Child, Preschool | 11 | 2021 | 14052 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 50 | 0.130 |
Why?
|
| Noonan Syndrome | 1 | 2016 | 30 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 1884 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2021 | 1018 | 0.130 |
Why?
|
| Infant, Newborn | 8 | 2021 | 8180 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2020 | 12278 | 0.120 |
Why?
|
| Transposition of Great Vessels | 3 | 2005 | 131 | 0.120 |
Why?
|
| Point Mutation | 1 | 2016 | 348 | 0.120 |
Why?
|
| Peripheral Nerves | 1 | 1995 | 85 | 0.120 |
Why?
|
| Spinal Neoplasms | 1 | 1995 | 59 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 200 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 1995 | 112 | 0.120 |
Why?
|
| Sarcoma, Ewing | 1 | 1995 | 117 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1995 | 128 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 1995 | 142 | 0.110 |
Why?
|
| Radiography | 2 | 2015 | 826 | 0.110 |
Why?
|
| Prognosis | 2 | 2017 | 4548 | 0.110 |
Why?
|
| Angiography | 2 | 2005 | 216 | 0.110 |
Why?
|
| Adult | 8 | 2018 | 29374 | 0.110 |
Why?
|
| Ethics Committees | 1 | 1993 | 2 | 0.110 |
Why?
|
| Ethics | 1 | 1993 | 23 | 0.110 |
Why?
|
| Child | 13 | 2022 | 24479 | 0.100 |
Why?
|
| Hospitalization | 1 | 2021 | 1752 | 0.100 |
Why?
|
| Professional Role | 1 | 1993 | 57 | 0.100 |
Why?
|
| Ethics Consultation | 1 | 1993 | 28 | 0.100 |
Why?
|
| Ethicists | 1 | 1993 | 41 | 0.100 |
Why?
|
| Professional Competence | 1 | 1993 | 97 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1999 | 669 | 0.090 |
Why?
|
| Brain | 1 | 2002 | 3000 | 0.090 |
Why?
|
| Pregnancy | 3 | 2018 | 7248 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 2128 | 0.080 |
Why?
|
| Computer Systems | 1 | 2007 | 38 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 229 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2022 | 16223 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 2007 | 35 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 69 | 0.070 |
Why?
|
| Pelvis | 1 | 2007 | 69 | 0.070 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 80 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2006 | 85 | 0.060 |
Why?
|
| Tachycardia, Sinus | 1 | 2005 | 7 | 0.060 |
Why?
|
| Heart Murmurs | 1 | 2005 | 15 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2008 | 306 | 0.060 |
Why?
|
| Tricuspid Atresia | 1 | 2005 | 14 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2005 | 64 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2005 | 969 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2005 | 70 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 142 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2005 | 169 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 118 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1690 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 1217 | 0.060 |
Why?
|
| Mutation | 1 | 2017 | 5804 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 276 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2006 | 197 | 0.050 |
Why?
|
| Aspirin | 1 | 2005 | 221 | 0.050 |
Why?
|
| Young Adult | 1 | 2017 | 8955 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2003 | 67 | 0.050 |
Why?
|
| Fever | 1 | 2005 | 296 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 153 | 0.050 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2002 | 22 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2002 | 33 | 0.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2003 | 64 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2006 | 462 | 0.050 |
Why?
|
| Spine | 1 | 2003 | 143 | 0.050 |
Why?
|
| Evoked Potentials, Motor | 1 | 2002 | 33 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 80 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2003 | 174 | 0.050 |
Why?
|
| Systole | 1 | 2022 | 197 | 0.050 |
Why?
|
| Acute Disease | 2 | 2021 | 1099 | 0.050 |
Why?
|
| Myocardium | 1 | 2006 | 1001 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 450 | 0.040 |
Why?
|
| Cineangiography | 1 | 1999 | 17 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2021 | 178 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 498 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1330 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 3371 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 114 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1999 | 145 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 1999 | 425 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 1999 | 226 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 356 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1107 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1174 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1306 | 0.030 |
Why?
|
| Gestational Age | 1 | 1999 | 1162 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2870 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1995 | 195 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 1995 | 186 | 0.030 |
Why?
|
| Age Factors | 3 | 2008 | 2812 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 2888 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1999 | 576 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3080 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3261 | 0.030 |
Why?
|
| Democracy | 1 | 1993 | 2 | 0.030 |
Why?
|
| Social Dominance | 1 | 1993 | 9 | 0.030 |
Why?
|
| Freedom | 1 | 1993 | 18 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2040 | 0.030 |
Why?
|
| Education | 1 | 1993 | 105 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1570 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 1993 | 134 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3412 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 1244 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1993 | 144 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1993 | 202 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1995 | 1396 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6259 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4729 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 4256 | 0.020 |
Why?
|
| Decision Making | 1 | 1993 | 656 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 586 | 0.020 |
Why?
|
| Troponin | 1 | 2006 | 72 | 0.020 |
Why?
|
| United States | 1 | 2021 | 10756 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2006 | 147 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2006 | 6087 | 0.020 |
Why?
|
| Reoperation | 1 | 2008 | 824 | 0.010 |
Why?
|
| Tachycardia | 1 | 2003 | 70 | 0.010 |
Why?
|
| Angiocardiography | 1 | 2002 | 13 | 0.010 |
Why?
|
| Heart Bypass, Right | 1 | 2002 | 17 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 2018 | 0.010 |
Why?
|
| Aortic Coarctation | 1 | 2004 | 106 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 128 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2003 | 151 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 374 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 580 | 0.010 |
Why?
|
| Hypotension | 1 | 2003 | 180 | 0.010 |
Why?
|
| Heart Rate | 1 | 2003 | 591 | 0.010 |
Why?
|
| Palliative Care | 1 | 2004 | 430 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1999 | 40 | 0.010 |
Why?
|
| Retreatment | 1 | 1999 | 88 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2002 | 632 | 0.010 |
Why?
|
| Equipment Design | 1 | 1999 | 609 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2008 | 3052 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 10124 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 19406 | 0.000 |
Why?
|